A randomised placebo controlled clinical trial investigating the role of a combination of probiotics and magnesium orotate for the management of depression.
NRGBiotic™ is a patented formulation created by Medlab Clinical’s researchers to positively influence mood disorders such as anxiety and depression. NRGBiotic™ promotes these effects by shifting the intestinal microbiome that, with the addition of other compounds re-establishes a neuroendocrine immunological balance in the gut between the intestines and the brain. NRGBiotic™ contains Magnesium Orotate and Coenzyme Q10 together with three probiotic genera.
CT- CT-2017-CTN-01080-1 v3
Queensland University of Technology